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Background: One of the most challenging issues of chronic Chagas disease is to provide earlier detection of heart
involvement. Two-dimensional speckle tracking (2-D ST) echocardiography, a new imagingmodalitywith useful
applications in several cardiac diseases, has been validated for subjectswithmyocardial infarction against cardiac
magnetic resonance (CMR). Here we hypothesize that the longitudinal global strain (LGS) has an incremental
value to ejection fraction for predicting myocardial ﬁbrosis in subjects with Chagas disease.
Methods: This observational study comprised 58 subjects with Chagas disease, conﬁrmed by two positive serologic
tests. All subjects underwent conventional Doppler echocardiogram plus speckle tracking strain, and cardiacmag-
netic resonance.
Results: The ROC curve analysis revealed that both LGS (areaunder the curve: 0.78, p=0.001) and ejection fraction
(area under the curve: 0.82, p b 0.001)were signiﬁcant predictors ofmyocardial ﬁbrosis. Regarding the percentage
of ﬁbrosis, a high correlation was observed with both ejection fraction assessed by echocardiography (r= 0.70,
p b 0.001) and LGS (r = 0.64, p b 0.001). However, when adjusted through multiple linear regression, the LGS
lost statistical signiﬁcance as a predictor of myocardial ﬁbrosis (p= 0.111).
Conclusions: LGShas no incremental value to conventional ejection fractionmeasurement in the prediction ofmyo-
cardial ﬁbrosis in subjects with Chagas disease.
© 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
In Chagas disease, myocardial ﬁbrosis affects not only the sinoatrial
node and Purkinje ﬁbers, but also intracardiac nervous ganglia and the
contractile myocardium [1]. Myocardial ﬁbrosis has been directly asso-
ciated with cardiac alterations such as ventricular dysfunction (highly
correlated with left ventricular ejection fraction [2]), and arrhythmias
(risk identiﬁcation for ventricular tachycardia [3]). The estimation of
myocardial ﬁbrosis in Chagas disease therefore may help in the early
detection of cardiac involvement. The best noninvasive technique to
evaluate myocardial ﬁbrosis for ischemic [4–6] and non-ischemic myo-
cardial diseases is magnetic resonance imaging (MRI), but this method
is still quite expensive, not widely available and contraindicated in sub-
jects with pacemakers.arcos, Salvador, BA 41253-190,
eliability and freedom from bias
land Ltd. This is an open access articlMyocardial ﬁbrosis has already been demonstrated to have a signif-
icant inverse correlation with left ventricular ejection fraction, and a di-
rect correlation with end-diastolic and end-systolic volume indices [2],
which indicates echocardiography as a possible method to indirectly
evaluate myocardial ﬁbrosis. One of the most challenging issues is the
identiﬁcation of ﬁbrosis in subjects with normal ejection fraction. In
this context, two-dimensional (2-D) speckle tracking (ST) echocardiog-
raphy could be a useful approach, since it provides an assessment of
myocardial deformation and left ventricular torsion [7]. Several studies
have demonstrated that longitudinal myocardial velocity, strain, and
strain rate are more sensitive and speciﬁc than LVEF for detecting
early myocardial dysfunction [8–10]. Moreover, a previous study has
shown that this new techniquewas also able to demonstratemyocardi-
al involvement, which was not evident in visual analysis from subjects
with the indeterminate form of Chagas disease [11].
Currently, the evaluation of Chagas disease subjects is performed by
conventional echocardiography and, to a lesser extent, by CMR imaging,
which is considered the gold standard method for measuring ejection
fraction. Although the 2-D ST for left ventricular quantiﬁcation has al-
ready been validated against cardiac magnetic resonance for subjectse under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 2
Echocardiographic and CMR ﬁndings.
Subjects (n= 58)
Echocardiogram
LVEF (%) 54.3 ± 15.2
LVEF b 55% 23 (39.7)
LV ESV (ml) 78.4 ± 66.4
LV EDV (ml) 174.5 ± 80.1
LV mass (g) 169.4 ± 59.8
LV LGS (%) −16.8 ± 5.6
LV LGS N−18% 29 (52.7)a
RV LGS (%) −20.4 ± 6.0
E/E′ ratio 10.3 ± 5.8
Tei index 0.54 ± 0.14
Systolic tricuspid annular velocity (cm/s) 11.3 ± 2.8
Propagation velocity by Color M-Mode (cm/s) 42.1 ± 15.1
CMR
LVEF (%) 55.8 ± 20.0
LV ESV (ml/m2) 82.4 ± 76.4
LV EDV (ml/m2) 161.9 ± 73.1
LV mass (g/m2) 121.5 ± 49.6
RVEF (%) 56.6 ± 13.8
RV ESV (ml/m2) 52.6 ± 33.2
RV EDV (ml/m2) 112.8 ± 38.9
Fibrosis (%) 2.2 (0–12.9)
DE 37 (63.8)
Continuous variables are expressed asmean± standard deviation ormedian (interquartile
interval) depending on normality assessed by the Shapiro–Wilk test. Categorical variables
are expressed as number of subjects (%).CMR = cardiac magnetic resonance; DE =
delayed enhancement; EDV = end diastolic volume; ESV = end systolic volume; LGS =
longitudinal global strain; LV = left ventricular; LVEF = left ventricular ejection fraction;
RV = right ventricular; RVEF = right ventricular ejection fraction.
a Three missing data for this variable.
Table 1
Subjects' clinical and demographic characteristics.
Subjects (n= 58)
Male gender 24 (41.4)
Age (years) 58 ± 9
Indeterminate form 17 (29.3)
Cardiac form without ventricular dysfunction 16 (27.6)
Cardiac form with ventricular dysfunction 25 (43.1)
NYHA III or IV 13 (22.4)
Hypertension 42 (72.4)
Diabetes 8 (13.8)
Current smoking 15 (25.9)
Hypercholesterolemia 27 (46.6)
RBBB 28 (49.1)a
Cardiomegaly 27 (46.6)
VT 15 (26.3)a
Hemoglobin (g/dl) 14.0 ± 0.98
Creatinine (mg/dl) 0.86 ± 0.17
Continuous variables are expressed as mean ± standard deviation. Categorical variables
are expressed as number of subjects (%). NYHA = New York Heart Association; RBBB =
right bundle-branch block; VT = ventricular tachycardia.
a One missing data for these variables.
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global strain against other echocardiographic variables, such as ejection
fraction (EF), using cardiac magnetic resonance (CMR) as the reference
standard, has not been evaluated in subjects with Chagas disease.
Therefore we hypothesize that the longitudinal global strain has an in-
cremental value to ejection fractionwhen predictingmyocardialﬁbrosis
in subjects with Chagas disease. To test our hypothesis, we performed a
correlation analysis between longitudinal global strain and ejection
fraction, both with myocardial ﬁbrosis, adjusting the variables through
multiple linear regression.
2. Methods
2.1. Study population
We conducted a cross-sectional study, in which adult subjects with
Chagas disease were invited to participate. From January 2011 to
December 2013, we included 58 subjects from a convenience sample,
in the Chagas disease outpatient clinics at our institution. The inclusion
criteria were disease established based onmicrobiological conﬁrmation
by two positive serologic tests (indirect hemagglutination and indirect
immunoﬂuorescence), and age between 18 and 70 years. The exclusion
criteria were: previous myocardial infarction or history of coronary
artery disease; primary valve disease; dialysis treatment of terminal
renal failure, chronic liver disease; hematologic, neoplastic or bone
diseases; and MRI contraindications.
The study complied with the Declaration of Helsinki and was
approved by the Ethics Committee of the Hospital São Rafael. All sub-
jects gave written informed consent before their inclusion in the study.
We obtained a structuredmedical history, and all subjects underwent
physical examination, blood analysis, 12-lead ECG, chest X-ray, 24-h
Holter monitoring, conventional Doppler echocardiogram plus speckle
tracking strain, and cardiac magnetic resonance.
2.2. Doppler echocardiogram
Standard transthoracic echocardiographic examinations were
recorded in all subjects using the Vivid 7 digital ultrasound system
(GE Vingmed Ultrasound AS, Horten, Norway). Three cardiac cycles
were stored in cine loop format for online analysis. LV and left atrial
dimensions were measured according to the American Society of Echo-
cardiography recommendations [13]. The LVEFwasmeasured using the
biplane Simpson's method. S0 systolic velocity at the lateral mitral
annulus was assessed using pulsed-wave DTI. Diastolic function was
evaluated by the analysis of the mitral Doppler inﬂow, pulsed- waveDTI at the lateral mitral annulus, and mitral propagation velocity using
Color M-mode echocardiography. Mitral regurgitation (MR) was
obtained using the proximal isovelocity surface areamethod. Right ven-
tricular function was assessed with the S0 systolic velocity in the lateral
wall. Systolic pulmonary arterial pressure was obtained from the tricus-
pid regurgitation ﬂow. In subjects with adequate Doppler MR signals,
dP/dt was determined noninvasively from the rate of change of MR
velocity, according to the American Society of Echocardiography
guidelines.
2.3. Strain measurements
Two-dimensional gray-scale images were acquired in the standard
apical four-chamber, three-chamber, and two-chamber views at a
frame rate of 80 frames/s. The dimensions of the computation area
were an angle of 80° and at a depth of 13 cm. The left ventricle was di-
vided into 17 segments, and each segment was analyzed individually.
GLS and segmental longitudinal strain were obtained as previously
described [14]. Average longitudinal strains were calculated automati-
cally by the software. The two-dimensional strain is a non-Doppler-
basedmethod for the evaluation of systolic strain using standard 2D ac-
quisitions. After placing three endocardial markers in an end-diastolic
frame, the software automatically tracks the contour on subsequent
frames. Adequate tracking can be veriﬁed in real time and corrected
by adjusting the region of interest or bymanually correcting the contour
to ensure optimal tracking. Two-dimensional longitudinal strain was
assessed in apical views. Average longitudinal strains were calculated
for the 17 segments.
2.4. Magnetic resonance imaging
Cardiac magnetic resonance exams were performed on all subjects
using the General Electric Sigma HDx 1.5-T system (Fairﬁeld, CT, USA).
Images were acquired and gated to the ECG during breath-hold, four-
chamber, short axis and long axis of the left ventricle, in the exact
Fig. 1. Ejection fraction assessed by Simpson (A) and left longitudinal global strain (B) in subjects with and without delayed enhancement detected by cardiac magnetic resonance.
*p b 0.001.
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between cardiac function and regional myocardial structure. The
parameters used in the dynamic sequences were repetition time (RT)
of 3.5 ms, echo time (ET) of 1.5 ms, ﬂip angle 60°, bandwidth of receipt
of ±125 kHz, ﬁeld of view (FOV) of 35 × 35 cm, 256 × 148matrix, tem-
poral resolution (TR) 35ms and 8.0mm slice thickness, without a space
between the slices. Following this acquisition, a dose of gadolinium-
based contrast (0.1 mmol/kg) was injected. The myocardial delayed
enhancement (MDE) technique was used to investigate myocardial
ﬁbrosis, an inversion-recovery prepared gradient-echo acquired 10 to
20min after contrast application, with the following parameters: Repe-
tition time (RT) 7.1 ms, echo time (ET) 3.1 ms, ﬂip angle 20°, cardiac
phase 1, views per segment 16 to 32, matrix 256 × 192, slice thickness
8mm, gap between slices 2mmand ﬁeld of view 32 to 38 cm, inversion
time 150 to 300 ms, receiver bandwidth 31.25 kHz, number of excita-
tions 2 and acquisition every heart beat. The mass of ﬁbrosis was esti-
mated by a quantitative visual method.Fig. 2. Receiver-operating characteristic (ROC) curves of left ventricular ejection fraction (A) an
under the curve) with 95% conﬁdence interval (95% CI) for the respective methods were: ejecti
0.65–0.90, p= 0.001).2.5. Statistical analysis
Categorical data were presented as numbers (percentages), and
continuous data were expressed as mean (SD) or median (interquartile
range). Comparisons of continuous variables among groups were per-
formed with the analysis of variance (ANOVA) test or Kruskal–Wallis,
depending on normality assessed by the Shapiro–Wilk test. Chi-
Square or Fisher tests were applied for proportion comparisons. Corre-
lations between continuous variables were evaluated by Pearson or
Spearman coefﬁcients, depending on normality. Receiver-operating
characteristic (ROC) curve analysis was used to evaluate if the longitu-
dinal global strain would add accuracy to the ejection fraction in the
predicted ﬁbrosis. C-Statistic (area under the curve) was presented as
a uniﬁed estimate of sensitivity and speciﬁcity. To determine the ability
to predict myocardial ﬁbrosis, multiple linear regression was per-
formed, including longitudinal global strain, left ventricular ejection
fraction, E/E′ ratio, Tei index, propagation velocity by Color M-Mode,d longitudinal global strain (B) for prediction of myocardial ﬁbrosis. The C-Statistic (area
on fraction: 0.82 (95% CI 0.72–0.96, p b 0.001); and longitudinal global strain: 0.78 (95% CI
Fig. 3. Correlation between EF assessed by Simpson (A) and left longitudinal global strain (B) withmyocardial ﬁbrosis assessed by CMR (linear regression). EF= ejection fraction. CMR=
cardiac magnetic resonance. p b 0.001 for both correlations.
78 C.T. Macedo et al. / IJC Heart & Vasculature 8 (2015) 75–80and systolic tricuspid annular velocity. The multiple linear regression
method used was forced entry, in which all predictors were entered si-
multaneously. Analyses in subgroups with normal and low ejection
fraction were also accomplished. Cases with missing data were not in-
cluded in the analysis. Analyses were performed using SPSS version
20.0 (IBM), and p b 0.05 (two-tailed) was considered statistically
signiﬁcant.Table 33. Results
3.1. Clinical and imaging characteristics
The study comprised 58 subjects, 41% were men, and the mean age
was58±9. The prevalenceof hypertension, diabetes, hypercholesterol-
emia and current smoking was 72%, 14%, 47% and 26%, respectively.
Regarding the clinical form of presentation, the subjects were distribut-
ed as follows: 17 (29%) with the indeterminate form (subjects with no
evidence of cardiac involvement or heart failure), 16 (28%) with the
cardiac form without ventricular dysfunction and 25 (43%) with the
cardiac form with ventricular dysfunction. Thirteen subjects were in
NYHA functional classes III–IV (22.4%) and 15 showed episodes of
ventricular tachycardia (26.3%). The clinical and demographic charac-
teristics of the subjects are described in Table 1.
The mean left ventricular ejection fraction assessed by Simpson was
54 ± 15%, and the mean left ventricular longitudinal global strain was
−16.8 ± 5.5. Abnormal left ventricular ejection fraction (b55%) and
abnormal longitudinal global strain (N−18%) were found in 39.7% and
52.7% of the subjects, respectively. Myocardial ﬁbrosis was observed in
37 subjects (63.8%). Echocardiographic and CMR data are described in
Table 2.Results of multiple linear regression analysis.
Standardized
regression
coefﬁcients β
Probability p
LV ejection fraction −0.905 0.003
Longitudinal global strain −0.904 0.111
E/E′ ratio 3.29 0.005
Tei index 39.49 0.023
Propagation velocity by Color M-Mode 0.110 0.369
Systolic tricuspid annular velocity 0.115 0.8153.2. Prediction of myocardial ﬁbrosis
The left ventricular ejection fraction (Simpsonmethod)was elevated
in subjects lacking delayed enhancement (64.5±6.7%)when compared
to subjectswho presented delayed enhancement on CMR (48.5±15.7%,
p b 0.001; Fig. 1A). We also found a signiﬁcant difference in longitudinal
global strain between subjects without andwith delayed enhancement,
−20.3 ± 3.2% and−14.7 ± 5.6%, respectively (p b 0.001; Fig. 1B).The ROC curve analysis revealed that both longitudinal global strain
(area under the curve: 0.78, 95% CI 0.65 to 0.90, p=0.001) and ejection
fraction (area under the curve: 0.82, 95% CI 0.72 to 0.96, p b 0.001) were
signiﬁcant predictors for myocardial ﬁbrosis (Fig. 2). For longitudinal
global strain, the cutoff points of −17.0, −18.0 and −19.0 have the
following sensitivity and speciﬁcity: 63% and 95%, 69% and 70%, and
77% and 60%, respectively. For the left ventricular ejection fraction, the
cutoff points of 49%, 55% and 60% have the following sensitivity and
speciﬁcity: 49% and 95%, 57% and 90%, and 65% and 81%, respectively.
Regarding thepercentage ofﬁbrosis, a high correlationwas observed
with ejection fraction assessed by echocardiography (r = 0.70,
beta=−0.55, 95%CI:−0.70 to−0.40, p b 0.001; Fig. 3A) andwith lon-
gitudinal global strain (r = 0.64, beta = 1.36, 95% CI: 0.91 to 1.82,
p b 0.001; Fig. 3B). However, when adjusted to other variables through
multiple linear regression, the longitudinal global strain lost statistical
signiﬁcance as a predictor of the percentage of ﬁbrosis (beta =−0.90,
95% CI:−2.0 to 0.24, p= 0.111). Left ventricular ejection fraction, Tei
index and E/E′ ratio were independent predictors of myocardial ﬁbrosis
(p= 0.003, p= 0.023 and p= 0.005, respectively). The results of the
multiple linear regression analysis (standardized regression coefﬁcients
β, and the probability p) are presented in Table 3.
3.3. Subgroup analysis
Analyzing subjects with normal left ventricular ejection fraction
(n= 35), we found a weak correlation with ejection fraction assessed
by echocardiography (r = 0.36, beta = −0.41, 95% CI: −0.76 to
Fig. 4. Correlation between EF assessed by Simpson (A) and left longitudinal global strain (B) with myocardial ﬁbrosis assessed by CMR (linear regression), in subjects with normal left
ventricular EF. EF = ejection fraction. CMR= cardiac magnetic resonance.
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0.51, 95% CI:−0.02 to 1.04, p=0.057) with the percentage of myocar-
dial ﬁbrosis (Fig. 4). Considering myocardial ﬁbrosis in subjects with
low left ventricular ejection fraction (n = 23), a moderate correlation
was observed with ejection fraction (Simpson method; r = 0.38,
beta=−0.60, 95% CI:−1.37 to 0.17, p=0.116) and aweak correlation
with longitudinal global strain (r=0.06, beta=−0.14, 95% CI:−1.5 to
1.2, p= 0.82; Fig. 5), both without statistical signiﬁcance.
4. Discussion
The present study evaluated myocardial deformation and LV torsion
assessed by 2-D ST echocardiography in a cohort of subjects in different
forms of chronic Chagas disease, to test the hypothesis that this new
parameter would add accuracy to the ejection fraction in the prediction
of myocardial ﬁbrosis. In current medical practice, ventricularFig. 5. Correlation between EF assessed by Simpson (A) and left longitudinal global strain (B) w
tricular EF. EF = ejection fraction. CMR = cardiac magnetic resonance.contractility is evaluated based on LVEF using the Simpson biplane
model by conventional echocardiography. However, this parameter
lacks sensitivity to identify early contractility impairment, since longitu-
dinal component and endocardial layers are the ﬁrst affected.Moreover,
ejection fractionmeasurement is highly dependent not only on operator
experience, but also on loading, which may lead to abnormal results
under unusual loading situations [15].
In this context, 2-D ST has emerged as a promising imagingmodality
to calculate regional tissue deformation, less subject to artifact, less
dependent on endocardial visualization and independent of geometric
assumptions. This method quantiﬁes myocardial deformation through
frame-by-frame tracking of a small image block of myocardial acoustic
markers. Already applied to several clinical conditions, this technique
has been shown to be an effective method for assessing LV function, re-
gardless of operator experience [7,14,16]. Nahumand co-workers previ-
ously reported that longitudinal global strain by ST is superior to LVEFith myocardial ﬁbrosis assessed by CMR (linear regression), in subjects with low left ven-
80 C.T. Macedo et al. / IJC Heart & Vasculature 8 (2015) 75–80and other longitudinal markers in identifying subjects with poor out-
come in a population with heart failure [17].
Previous studies have validated 2-D ST for LV quantiﬁcation against
magnetic resonance imaging, demonstrating the reliability of the
method in a clinical trial [18]. Although myocardial deformation by 2-
D ST had been characterized in a cohort of subjects with different
forms of Chagas disease [11], the data did not include validation against
left ventricular ejection fraction. Garcia-Álvarez and coworkers showed
that the average value of LGS for subjects with chronic Chagas cardiomy-
opathywas−16.5%, whereas in our study the averagewas−11.0%, pos-
sibly featuring a population of greater severity.
Our study showed a high percentage of delayed enhancement in the
three different forms of the disease: 41% for the indeterminate form,
47% for the cardiac form without ventricular dysfunction and 92% for
subjects with ventricular dysfunction. A previous study demonstrated
rates of 7.4%, 15.8% and 52.4% for these three groups of subjects, respec-
tively [19]. Despite this difference, the overall prevalence of delayed
enhancement in our population of subjects with chronic Chagas cardio-
myopathy, estimated at 92%, is consistent with literature data, since
global prevalence has demonstrated delayed enhancement ranging
from 68.6% to 88.9% in this proﬁle of subjects [2].
We also demonstrated a high correlation between EF assessed by
Simpson and longitudinal global strain with myocardial ﬁbrosis
assessed by CMR, both with statistical signiﬁcance. However, one of
the issues that we wanted to address in our study was if the use of
2-D ST would have an incremental role to ejection fraction on the pre-
diction of myocardial ﬁbrosis, which was shown not to be true, since
the longitudinal global strain became non-signiﬁcant when adjusted
to the ejection fraction and to other important echocardiographic vari-
ables. Unlike the longitudinal global strain, the Tei index and the E/E′
ratio were statistically signiﬁcant as independent predictors of myocar-
dial ﬁbrosis. Since myocardial ﬁbrosis increases the left ventricular dia-
stolic pressure, leading to alterations in the left ventricular relaxation,
these parameters may be indicative of early cardiac involvement.
One limitation of our study was that a more complex investigation to
rule out coronary artery disease was not performed. However, subjects
with a history of acutemyocardial infarction or chronic coronary artery dis-
ease were excluded. In addition, all subjects underwent a treadmill stress
test, an exam with a high negative predictive value for subjects without
symptoms of ischemic heart disease, and no ischemia was demonstrated.
It is already known that the evaluation of LV function is crucial in sub-
jectswith Chagas disease, as ventricular dysfunction is an independent pre-
dictor of mortality in this group of subjects [20]. We studied the role of the
longitudinal global strain as a possible method to add accuracy to ejection
fraction in thepredictionofmyocardialﬁbrosis, butwedidnotdemonstrate
superiority of this new technique, leading to the conclusion that the longi-
tudinal global strain has no incremental value to conventional ejection frac-
tion measurement in subjects with Chagas disease. Since every new
technique comes up with a great enthusiasm in its use, even before strong
scientiﬁc evidence conﬁrms its usefulness, it is crucial to develop studies
testing a new method against other well-established ones, in order to
have a critical view of the diagnostic exams available in clinical practice.
Funding
This work was ﬁnancially supported by FAPESB: Fundação de
Amparo à Pesquisa do Estado da Bahia (00003841).
Conﬂicts of interest
None.
Acknowledgments
The authors thank Dr. Kyan James Allahdadi for a careful review of
the manuscript.References
[1] Andrade ZA, Andrade SG, Oliveira GB, Alonso DR. Histopathology of the conducting
tissue of the heart in Chagas' myocarditis. Am Heart J 1978;95(3):316–24.
[2] Rochitte CE, Oliveira PF, Andrade JM, Ianni BM, Parga JR, Avila LF, et al. Myocardial
delayed enhancement by magnetic resonance imaging in patients with Chagas' dis-
ease: a marker of disease severity. J Am Coll Cardiol 2005;46(8):1553–8. http://dx.
doi.org/10.1016/j.jacc.2005.06.067 [published Online First: Epub Date].
[3] Mello RP, Szarf G, Schvartzman PR, Nakano EM, Espinosa MM, Szejnfeld D, et al. De-
layed enhancement cardiac magnetic resonance imaging can identify the risk for
ventricular tachycardia in chronic Chagas' heart disease. Arq Bras Cardiol 2012;
98(5):421–30.
[4] Wagner A, Mahrholdt H, Holly TA, Elliott MD, Regenfus M, Parker M, et al. Contrast-
enhanced MRI and routine single photon emission computed tomography (SPECT)
perfusion imaging for detection of subendocardial myocardial infarcts: an imaging
study. Lancet 2003;361(9355):374–9. http://dx.doi.org/10.1016/S0140-
6736(03)12389-6 [published Online First: Epub Date].
[5] Rochitte CE, Lima JA, Bluemke DA, Reeder SB, McVeigh ER, Furuta T, et al. Magnitude
and time course of microvascular obstruction and tissue injury after acute myocar-
dial infarction. Circulation 1998;98(10):1006–14.
[6] McCrohon JA, Moon JC, Prasad SK, McKenna WJ, Lorenz CH, Coats AJ, et al. Differen-
tiation of heart failure related to dilated cardiomyopathy and coronary artery dis-
ease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation
2003;108(1):54–9. http://dx.doi.org/10.1161/01.CIR.0000078641.19365.4C [pub-
lished Online First: Epub Date].
[7] Blessberger H, Binder T. Two dimensional speckle tracking echocardiography: clini-
cal applications. Heart 2010;96(24):2032–40. http://dx.doi.org/10.1136/hrt.2010.
199885 [published Online First: Epub Date].
[8] Koyama J, Ray-Sequin PA, Falk RH. Longitudinal myocardial function assessed by
tissue velocity, strain, and strain rate tissue Doppler echocardiography in patients
with AL (primary) cardiac amyloidosis. Circulation 2003;107(19):2446–52. http://
dx.doi.org/10.1161/01.CIR.0000068313.67758.4F [published Online First: Epub
Date].
[9] Richand V, Laﬁtte S, Reant P, Serri K, Laﬁtte M, Brette S, et al. An ultrasound speckle
tracking (two-dimensional strain) analysis of myocardial deformation in professional
soccer players compared with healthy subjects and hypertrophic cardiomyopathy.
Am J Cardiol 2007;100(1):128–32. http://dx.doi.org/10.1016/j.amjcard.2007.02.063
[published Online First: Epub Date].
[10] Laﬁtte S, Perlant M, Reant P, Serri K, Douard H, DeMaria A, et al. Impact of impaired
myocardial deformations on exercise tolerance and prognosis in patients with
asymptomatic aortic stenosis. Eur J Echocardiogr 2009;10(3):414–9. http://dx.doi.
org/10.1093/ejechocard/jen299 [published Online First: Epub Date].
[11] García-Álvarez A, Sitges M, Regueiro A, Poyatos S, Jesus Pinazo M, Posada E, et al.
Myocardial deformation analysis in Chagas heart disease with the use of speckle
tracking echocardiography. J Card Fail 2011;17(12):1028–34. http://dx.doi.org/10.
1016/j.cardfail.2011.08.007 [published Online First: Epub Date].
[12] Brown J, Jenkins C,Marwick TH. Use ofmyocardial strain to assess global left ventric-
ular function: a comparison with cardiac magnetic resonance and 3-dimensional
echocardiography. Am Heart J 2009;157(1):102.e1–5. http://dx.doi.org/10.1016/j.
ahj.2008.08.032 [published Online First: Epub Date].
[13] Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recom-
mendations for chamber quantiﬁcation: a report from the American Society of
Echocardiography's Guidelines and Standards Committee and the Chamber Quanti-
ﬁcation Writing Group, developed in conjunction with the European Association of
Echocardiography, a branch of the European Society of Cardiology. J Am Soc
Echocardiogr 2005;18(12):1440–63. http://dx.doi.org/10.1016/j.echo.2005.10.005
[published Online First: Epub Date].
[14] Leitman M, Lysyansky P, Sidenko S, Shir V, Peleg E, Binenbaum M, et al. Two-
dimensional strain—a novel software for real-time quantitative echocardio-
graphic assessment of myocardial function. J Am Soc Echocardiogr 2004;
17(10):1021–9. http://dx.doi.org/10.1016/j.echo.2004.06.019 [published On-
line First: Epub Date].
[15] Marwick TH. Shouldwe be evaluating the ventricle or themyocardium? Advances in
tissue characterization. J Am Soc Echocardiogr 2004;17(2):168–72. http://dx.doi.
org/10.1016/j.echo.2003.10.021 [published Online First: Epub Date].
[16] Belghitia H, Brette S, Laﬁtte S, Reant P, Picard F, Serri K, et al. Automated function im-
aging: a new operator-independent strain method for assessing left ventricular
function. Arch Cardiovasc Dis 2008;101(3):163–9.
[17] Nahum J, Bensaid A, Dussault C, Macron L, Clémence D, Bouhemad B, et al. Impact of
longitudinal myocardial deformation on the prognosis of chronic heart failure pa-
tients. Circ Cardiovasc Imaging 2010;3(3):249–56. http://dx.doi.org/10.1161/
CIRCIMAGING.109.910893 [published Online First: Epub Date].
[18] Amundsen BH, Helle-Valle T, Edvardsen T, Torp H, Crosby J, Lyseggen E, et al. Nonin-
vasive myocardial strain measurement by speckle tracking echocardiography: vali-
dation against sonomicrometry and tagged magnetic resonance imaging. J Am Coll
Cardiol 2006;47(4):789–93. http://dx.doi.org/10.1016/j.jacc.2005.10.040 [published
Online First: Epub Date].
[19] Regueiro A, García-Álvarez A, Sitges M, Ortiz-Pérez JT, De Caralt MT, Pinazo MJ, et al.
Myocardial involvement in Chagas disease: insights from cardiac magnetic reso-
nance. Int J Cardiol 2013;165(1):107–12. http://dx.doi.org/10.1016/j.ijcard.2011.07.
089 [published Online First: Epub Date].
[20] Rassi A, LittleWC, Xavier SS, Rassi SG, Rassi AG, Rassi GG, et al. Development and val-
idation of a risk score for predicting death in Chagas' heart disease. N Engl J Med
2006;355(8):799–808. http://dx.doi.org/10.1056/NEJMoa053241355/8/799 [pii]
[published Online First: Epub Date].
